196 related articles for article (PubMed ID: 23211959)
1. Intractable nausea and vomiting from autoantibodies against a brain water channel.
Iorio R; Lucchinetti CF; Lennon VA; Farrugia G; Pasricha PJ; Weinshenker BG; Pittock SJ
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):240-5. PubMed ID: 23211959
[TBL] [Abstract][Full Text] [Related]
2. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
3. Intractable nausea and vomiting as an uncommon presentation in an anti-aquaporin 4-positive patient.
Wang L; Su HJ; Qi JL; E RF; Zhao K
J Int Med Res; 2018 Aug; 46(8):3411-3416. PubMed ID: 29806512
[TBL] [Abstract][Full Text] [Related]
4. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
6. Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.
Iorio R; Damato V; Mirabella M; Evoli A; Marti A; Plantone D; Frisullo G; Batocchi AP
J Neurol; 2013 Sep; 260(9):2396-402. PubMed ID: 23793787
[TBL] [Abstract][Full Text] [Related]
7. Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD.
Shosha E; Dubey D; Palace J; Nakashima I; Jacob A; Fujihara K; Takahashi T; Whittam D; Leite MI; Misu T; Yoshiki T; Messina S; Elsone L; Majed M; Flanagan E; Gadoth A; Huebert C; Sagen J; Greenberg BM; Levy M; Banerjee A; Weinshenker B; Pittock SJ
Neurology; 2018 Oct; 91(17):e1642-e1651. PubMed ID: 30258024
[TBL] [Abstract][Full Text] [Related]
8. Aquaporin-4 autoimmunity in a child without optic neuritis and myelitis.
Numata Y; Uematsu M; Suzuki S; Miyabayashi T; Oyama T; Kubota S; Itoh T; Hino-Fukuyo N; Takahashi T; Kure S
Brain Dev; 2015 Jan; 37(1):149-52. PubMed ID: 24750850
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.
Guerra H; Pittock SJ; Moder KG; Fryer JP; Gadoth A; Flanagan EP
Mayo Clin Proc; 2018 Sep; 93(9):1299-1304. PubMed ID: 29655487
[TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Hinson SR; Lennon VA; Pittock SJ
Handb Clin Neurol; 2016; 133():377-403. PubMed ID: 27112688
[TBL] [Abstract][Full Text] [Related]
12. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
13. [The clinical analyses of neuromyelitis optica spectrum disorder initially presenting with area postrema syndrome in 14 patients].
Guo QF; Song DD; Wang QQ; Wang ZW; Liu JG; Qi XK
Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):358-362. PubMed ID: 28460507
[No Abstract] [Full Text] [Related]
14. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A Rare Case of Advanced Breast Cancer with Intractable Nausea and Vomiting.
Miyagishima D; Anezaki T; Fukuda A; Watanabe H; Hata M; Eguchi M
Am J Case Rep; 2023 Nov; 24():e941808. PubMed ID: 37933098
[TBL] [Abstract][Full Text] [Related]
16. Recurrent episodes of syncope requiring pacemaker implantation as an initial presentation of neuromyelitis optica spectrum disorder.
Tsouris Z; Dastamani M; Siokas V; Aloizou AM; Zagouras A; Provatas A; Tsimourtou V; Dardiotis E
Mult Scler Relat Disord; 2020 Oct; 45():102423. PubMed ID: 32745996
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP
Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.
Sepúlveda M; Sola-Valls N; Escudero D; Rojc B; Barón M; Hernández-Echebarría L; Gómez B; Dalmau J; Saiz A; Graus F
Mult Scler; 2018 Nov; 24(13):1753-1759. PubMed ID: 28920766
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
20. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
